Evaluation of the influence of physiological anti-coagulant factor, inflammation, and aging on the various anti-coagulation therapies

Evaluation of the influence of physiological anti-coagulant factor, inflammation, and aging on the various anti-coagulation therapies - Evaluation of the influence of physiological anti-coagulant factor, inflammation, and aging on the various anti-coagulation therapies

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000019496

Enrollment

100

Registered

2015-11-01

Start date

2014-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation, paroxysmal supraventricular tachycardia, ventricular arrhythmias, and patients with cardiac Implantable electronic device (CIED)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult patients with arrhythmias who fit the indication of radiofrequency catheter ablation for arrhythmias and/or CIED therapy

Exclusion criteria

Exclusion criteria: The patient without prior written consent, and the patient who receives urgent treatment.

Design outcomes

Primary

Measure	Time frame
Major bleeding complication, ischemic stroke, TIA, systemic embolism	—

Countries

Japan

Contacts

Public ContactDaisuke Izumi

Niigata University Graduate School of Medical and Dental Sciences Department of Cardiovascular Biology and Medicine

dizumi@med.niigata-u.ac.jp+81-25-227-2185

Outcome results